Literature DB >> 2893121

Amoxycillin/clavulanate resistant Escherichia coli.

H Williams, A King, K Shannon, I Phillips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2893121     DOI： 10.1016/s0140-6736(88)90391-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.

Authors:  V A Steingrube; R J Wallace; B A Brown; Y Pang; B Zeluff; L C Steele; Y Zhang
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Synergistic effect of dosage and bacterial inoculum in TEM-1 mediated antibiotic resistance.

Authors:  J A Reguera; F Baquero; J C Perez-Diaz; J L Martinez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

3.  Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.

Authors:  P J Wu; K Shannon; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

Review 4.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

5.  Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model.

Authors:  L B Rice; L L Carias; D M Shlaes
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

6.  Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms.

Authors:  L B Rice; L L Carias; L Etter; D M Shlaes
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

Review 7.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

8.  Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.

Authors:  Mohammad Faheem; Md Tabish Rehman; Mohd Danishuddin; Asad U Khan
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.